Press releases
- Accuray Showcases Advances in Radiation Therapy Solutions Designed to Improve the Cancer Treatment Experience at ESTRO 2024
- Accuray Expands Global Training Center Network With Opening of New Facility in Genolier, Switzerland
- Accuray to Report Third Quarter Fiscal 2024 Financial Results on May 1, 2024
- New Data from Two Clinical Studies Indicate High-Risk and Recurrent Prostate Cancers Can be Effectively Treated in 5 Days Using the Accuray CyberKnife® System
- Accuray Incorporated to Speak at Oppenheimer 34th Annual Healthcare MedTech & Services Conference
- Quebec Cancer Center is First in Canada to Treat Cancer Patients Using the Accuray Radixact® System
- Accuray to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
- Accuray Reports Fiscal 2024 Second Quarter Financial Results
More ▼
Key statistics
On Thursday, Accuray Inc (ARAY:DEU) closed at 1.98, 1.02% above its 52-week low of 1.96, set on Apr 22, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.02 |
---|---|
High | 2.06 |
Low | 1.98 |
Bid | 2.02 |
Offer | 2.04 |
Previous close | 2.02 |
Average volume | 626.89 |
---|---|
Shares outstanding | 99.17m |
Free float | 95.62m |
P/E (TTM) | -- |
Market cap | 216.19m USD |
EPS (TTM) | -0.1496 USD |
Data delayed at least 15 minutes, as of Apr 25 2024.
More ▼